US Patent 7879823 Topical anti-cancer compositions and methods of use thereof
Patent 7879823 was granted and assigned to Johnson & Johnson on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+237 characters)
Article
Patent abstract
Described are skin-care compositions containing non denatured soy products and optionally other anti-cancer or anti-aging agents. The compositions can be applied topically to reduce the risk of UV-induced cutaneous tumors.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07879823 Topical anti-cancer compositions and methods of use thereof US Patent 7879823 Topical anti-cancer compositions and methods of use thereof
Infobox
Patent Number
0787982300
Patent Number
787982300
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078798230
Date of Patent
February 1, 2011
0Patent Application Number
108853240
Date Filed
July 6, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078798230
Date of Patent
February 1, 2011
0Patent Application Number
108853240
Date Filed
July 6, 2004
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07879823 Topical anti-cancer compositions and methods of use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07879823
Date of patent
February 1, 2011
Patent application number
10885324
Date Filed
July 6, 2004
Patent primary examiner
Find more entities like US Patent 7879823 Topical anti-cancer compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.